Nikhil Meena
Professor
Also affiliated: University of Arkansas Medical Center (2015–2025); Cooper University Hospital (2015); Jefferson Einstein Philadelphia Hospital (2017); Central Arkansas Veterans Healthcare System (2010–2018); Zakłady Magnezytowe (Poland) (2017); Winthrop Rockefeller Foundation (2019); Issues Research (2016–2017); Arkansas Department of Agriculture (2023); Pulmonary and Critical Care Associates (2016)
Faculty Researcher
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Nikhil Meena, a professor in Internal Medicine at the University of Arkansas for Medical Sciences, has a research focus that includes the evaluation of diagnostic criteria for secondary hemophagocytic lymphohistiocytosis, robotic bronchoscopy for peripheral pulmonary lesion biopsy, and competency assessment in electromagnetic navigation bronchoscopy. His work has explored Bayesian methods for sepsis trials and conducted meta-analyses on mediastinal cryobiopsy versus endobronchial ultrasound-transbronchial needle aspiration for intrathoracic adenopathy diagnosis. Dr. Meena has also investigated the association between tocilizumab use and an increased risk of fungal infections in critically ill COVID-19 patients with acute renal failure, as well as the feasibility of rapid on-site cytologic evaluation using ancillary interventional pulmonary personnel. His scholarship metrics include an h-index of 18, with 122 total publications and 896 total citations.
Metrics
- h-index: 18
- Publications: 122
- Citations: 906
Selected Publications
-
Reply to Seelay: EBRT vs Bronchoscopy for MCAO: apples and oranges are not the same (2026)
-
Reply to Schwartz: EBRT and Interventions for Malignant Central Airway Obstruction: A False Dichotomy (2026)
-
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial (2026)
-
Real-world faceoff: EBRT vs interventions for malignant central airway obstruction (2026)
-
American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer (2025)
-
Delivering a Regional Procedural Bootcamp for Incoming Pulmonary and Critical Care Medicine Fellows (2025)
-
Radiation exposure trends with augmented fluoroscopy and C-arm-based tomosynthesis for navigated bronchoscopy (2025)
-
1635: INCIDENCE OF ENDOTOXIC SEPTIC SHOCK IN THE US AND CANADA (2025)
-
Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteria (2025)
-
Evaluating the Effect of Body Mass Index on Procalcitonin Level in Patients with Pneumonia: A Retrospective Cross-Sectional Study (2025)
-
Meta-analysis and systematic review of mediastinal cryobiopsy versus endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of intrathoracic adenopathy (2024)
-
Correction to: Bayesian methods: a potential path forward for sepsis trials (2024)
-
Bayesian methods: a potential path forward for sepsis trials (2023)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319) Savara, Inc Principal Investigator
- A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients with Endotoxemic Septic Shock: TIGRIS TRIAL (IRB 262982) Spectral Medical, Inc Principal Investigator
- A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (IRB 262510) NIH/Nat. Inst. of Allergy & Infectious Diseases via Leidos Principal Investigator
Collaboration Network
Top Collaborators
- Meta-analysis and systematic review of mediastinal cryobiopsy versus endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of intrathoracic adenopathy
- Rapid On-Site Cytologic Evaluation: A Feasibility Study Using Ancillary Interventional Pulmonary Personnel
- The Association of “GOOP” on Gross Examination of Fine Needle Aspiration Samples and On-Site Adequacy
- Radiation exposure trends with augmented fluoroscopy and C-arm-based tomosynthesis for navigated bronchoscopy
- Real-world faceoff: EBRT vs interventions for malignant central airway obstruction
- Meta-analysis and systematic review of mediastinal cryobiopsy versus endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) in the diagnosis of intrathoracic adenopathy
- Rapid On-Site Cytologic Evaluation: A Feasibility Study Using Ancillary Interventional Pulmonary Personnel
- The Association of “GOOP” on Gross Examination of Fine Needle Aspiration Samples and On-Site Adequacy
- Radiation exposure trends with augmented fluoroscopy and C-arm-based tomosynthesis for navigated bronchoscopy
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- A 34-Year-Old Man With Lightheadedness and Dyspnea
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience
- Rapid On-Site Cytologic Evaluation: A Feasibility Study Using Ancillary Interventional Pulmonary Personnel
- The yield and impact of pulmonologist-performed EUS-B-FNA of subdiaphragmatic lesions—an institutional experience
- The Association of “GOOP” on Gross Examination of Fine Needle Aspiration Samples and On-Site Adequacy
- A 41-Year-Old Man Presenting With Shortness of Breath, Nausea, Vomiting, and Diarrhea
- A 72-Year-Old Woman With Dyspnea, Multiple Pulmonary Nodules, and Mediastinal Lymphadenopathy
- A 34-Year-Old Man With Lightheadedness and Dyspnea
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Robotic Bronchoscopy for Peripheral Pulmonary Lesion Biopsy: Evidence-Based Review of the Two Platforms
- The Association of “GOOP” on Gross Examination of Fine Needle Aspiration Samples and On-Site Adequacy
- A 34-Year-Old Man With Lightheadedness and Dyspnea
- Robotic Bronchoscopy for Peripheral Pulmonary Lesion Biopsy: Evidence-Based Review of the Two Platforms
- A 72-Year-Old Woman With Dyspnea, Multiple Pulmonary Nodules, and Mediastinal Lymphadenopathy
- A 34-Year-Old Man With Lightheadedness and Dyspnea
- Bayesian methods: a potential path forward for sepsis trials
- 1635: INCIDENCE OF ENDOTOXIC SEPTIC SHOCK IN THE US AND CANADA
- Correction to: Bayesian methods: a potential path forward for sepsis trials
- Robotic Bronchoscopy for Peripheral Pulmonary Lesion Biopsy: Evidence-Based Review of the Two Platforms
- A 41-Year-Old Man Presenting With Shortness of Breath, Nausea, Vomiting, and Diarrhea
- 303: A PANDEMIC WITHIN AN EPIDEMIC: EVALUATION OF COVID-19 IN THE OBESE POPULATION
- 195: ZINC USE IS ASSOCIATED WITH IMPROVED OUTCOMES IN COVID-19: RESULTS FROM THE CRUSH-COVID REGISTRY
- 303: A PANDEMIC WITHIN AN EPIDEMIC: EVALUATION OF COVID-19 IN THE OBESE POPULATION
- 195: ZINC USE IS ASSOCIATED WITH IMPROVED OUTCOMES IN COVID-19: RESULTS FROM THE CRUSH-COVID REGISTRY
Similar Researchers
Based on overlapping research topics